Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ESSA Pharma Inc EPIX

Healthcare Biotechnology
ESSA Pharma Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is focused on developing proprietary therapies for the treatment of patients with prostate cancer. Its lead candidate, EPI-7386, is an oral, small molecule that inhibits the N-terminal domain of the androgen receptor (AR). The Company is completing the initial Phase I clinical development of EPI-7386 as a... see more

Recent & Breaking News (NDAQ:EPIX)

ESSA Pharma Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2019

PR Newswire March 28, 2019

ESSA Pharma Announces Nomination of EPI-7386 as Lead Clinical Candidate in Metastatic Castration-Resistant Prostate Cancer

Canada NewsWire March 28, 2019

ESSA Pharma to Present at the Oppenheimer 29th Annual Healthcare Conference

Canada NewsWire March 18, 2019

ESSA Pharma to Attend the 31st Annual ROTH Conference

Canada NewsWire March 14, 2019

ESSA Pharma Announces Two Abstracts Selected to be Presented at the 2019 Genitourinary Cancers Symposium

Canada NewsWire February 11, 2019

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2018

PR Newswire February 7, 2019

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2018

PR Newswire December 13, 2018

Investor Expectations to Drive Momentum within Townsquare Media, Koss, ESSA Pharma, MVC Capital, Valeritas, and Sonic Foundry — Discovering Underlying Factors of Influence

GlobeNewswire November 14, 2018

ESSA Appoints Otello Stampacchia, PH.D., of Omega Funds to Board of Directors

PR Newswire October 22, 2018

ESSA Pharma to Present at 20th Annual Global Investment Conference In New York City September 4 - 6, 2018

Canada NewsWire August 29, 2018

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2018

Canada NewsWire August 14, 2018

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2018

PR Newswire May 14, 2018

Essa Pharma Inc. Regains Compliance with NASDAQ Listing Requirements

PR Newswire May 10, 2018

55 Biggest Movers From Yesterday

Benzinga.com  May 4, 2018

42 Biggest Movers From Yesterday

Benzinga.com  May 2, 2018

ESSA to present at Bloom Burton & Co. Healthcare Investor Conference 2018

Canada NewsWire April 26, 2018

ESSA Pharma Inc. Announces Completion of Share Consolidation

Canada NewsWire April 25, 2018

ESSA Pharma Enhances R&D Capabilities with Two New Key Hires

Canada NewsWire April 24, 2018

ESSA Pharma Inc. Announces Share Consolidation

Canada NewsWire April 19, 2018

ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders

Canada NewsWire March 28, 2018